TEAM SCIENCE

aims to catalyze sharing of integrated genomic and clinical datasets across multiple institutions worldwide, and thereby enable precision cancer medicine research, including the identification of novel therapeutic targets, design of biomarker-driven clinical trials, and identification of genomic determinants of response to therapy.

This infrastructure initiative aims at providing a nationally accessible infrastructure for standardized analyses of a wide collection of parameters relevant to immune mediated tumour-control and therefore N-CIA will support the standardized sampling of tumour and blood of metastatic cancer patients.

The purpose of this Working Group is to develop, in a timely manner, standards on the assessment of Immuno-Oncology Biomarkers to aid pathologists, clinicians and researchers in their research and daily practice.